FMO5 and chronic obstructive pulmonary disease: In contrast, individuals with sustained CFTR dysfunction such as in CF and possibly COPD (Dransfield et al., 2013) are at risk of prolonged NADPH oxidase inhibition, thus preventing optimal killing of pathogens and resolution of inflammation, as observed herein in the case of neutrophils incubated with CFAM.